NASDAQ:UTHR

United Therapeutics Short Interest Ratio and Short Volume

$200.08
-5.06 (-2.47 %)
(As of 09/17/2021 12:00 AM ET)
Add
Compare
Today's Range
$199.06
$204.98
50-Day Range
$179.86
$214.88
52-Week Range
$98.37
$216.90
Volume591,346 shs
Average Volume354,381 shs
Market Capitalization$8.99 billion
P/E Ratio19.44
Dividend YieldN/A
Beta0.49

United Therapeutics (NASDAQ:UTHR) Short Interest Data

Current Short Volume3,240,000 shares
Previous Short Volume1,920,000 shares
Change Vs. Previous Month+68.75%
Dollar Volume Sold Short$696.21 million
Short Interest Ratio / Days to Cover9.8
Last Record DateAugust, 31 2021
Outstanding Shares44,923,000 shares
Float Size43,890,000 shares
Short Percent of Float7.38%
Today's Trading Volume591,346 shares
Average Trading Volume354,381 shares
Today's Volume Vs. Average66.87%

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling United Therapeutics ?

Sign up to receive the latest short interest report for United Therapeutics and its competitors with MarketBeat's FREE newsletter.

United Therapeutics (NASDAQ:UTHR) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/20213,240,000 shares $696.21 million +68.8%7.4%9.8 $214.88
8/13/20211,920,000 shares $389.03 million +18.5%4.4%5.4 $202.62
7/30/20211,620,000 shares $294.73 million -3.6%3.7%4.7 $181.93
7/15/20211,680,000 shares $309.44 million -4.6%3.8%5.5 $184.19
6/30/20211,760,000 shares $315.76 million No Change4.0%5.4 $179.41
6/15/20211,760,000 shares $314.07 million +0.6%4.0%4.6 $178.45
5/28/20211,750,000 shares $325.33 million -3.9%4.0%4.5 $185.90
5/14/20211,820,000 shares $352.66 million -9.9%4.2%4.8 $193.77
4/30/20212,020,000 shares $412.56 million No Change4.6%5.4 $204.24
4/15/20212,020,000 shares $409.62 million -13.7%4.7%5.5 $202.78
3/31/20212,340,000 shares $387.20 million +3.1%5.4%6 $165.47
3/15/20212,270,000 shares $362.07 million +18.2%5.2%6.7 $159.50
2/26/20211,920,000 shares $324.10 million +10.3%4.4%5.7 $168.80
2/12/20211,740,000 shares $294.98 million -1.1%4.0%5.4 $169.53
1/29/20211,760,000 shares $289.33 million +1.2%4.1%5.2 $164.39
1/15/20211,740,000 shares $291.03 million -7.9%4.0%4.4 $167.26
12/31/20201,890,000 shares $281.01 million -5.0%4.4%4.5 $148.68
12/15/20201,990,000 shares $284.85 million -3.9%4.6%4.9 $143.14
11/30/20202,070,000 shares $280.57 million -7.2%4.8%5.2 $135.54
10/30/20202,520,000 shares $328.23 million +12.5%5.8%6.8 $130.25
10/15/20202,240,000 shares $246.31 million +9.8%5.2%6.9 $109.96
9/30/20202,040,000 shares $206.04 million +10.9%4.7%7 $101.00
9/15/20201,840,000 shares $194.58 million No Change4.3%5.4 $105.75
8/31/20201,840,000 shares $196.81 million +10.8%4.3%4.7 $106.96
8/14/20201,660,000 shares $181.72 million -0.6%3.8%3.7 $109.47

Institutional Investors Shorting United Therapeutics (NASDAQ:UTHR)

This table shows institutional investors, funds, and major shareholders that have reported short positions as of their most recent reporting period. Most commonly, these investors have purchased put options on shares of United Therapeutics. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Reporting DateInvestor NameShares Shorted (Previous)Shares Shorted (Current)Position ChangePosition Size
8/17/2021Walleye Trading LLC46,30024,100-47.9%$4,324.00
8/17/2021Citadel Advisors LLC105,90038,800-63.4%$6,961.00
8/16/2021SG3 Management LLC15,0000-100.0%$0.00
8/16/2021Goldman Sachs Group Inc.N/A10,000N/A$1,794.00
8/12/2021Simplex Trading LLC720-100.0%$0.00
8/11/2021Susquehanna International Group LLP75,00014,400-80.8%$2,584.00
8/6/2021Wolverine Trading LLC5,70013,800+142.1%$2,443.00

United Therapeutics (NASDAQ:UTHR) Short Interest FAQ

speech bubbles
speech bubbles











What is United Therapeutics' current short interest?

Short interest is the volume of United Therapeutics shares that have been sold short but have not yet been covered or closed out. As of August 31st, investors have sold 3,240,000 shares of UTHR short. 7.38% of United Therapeutics' shares are currently sold short. Learn More on United Therapeutics' current short interest.

What is a good short interest ratio for United Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. United Therapeutics currently has a short interest ratio of 10.0. Learn More on a good short interest ratio for United Therapeutics

Which institutional investors are shorting United Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of United Therapeutics: Walleye Trading LLC, Citadel Advisors LLC, SG3 Management LLC, Goldman Sachs Group Inc., Simplex Trading LLC, Susquehanna International Group LLP, and Wolverine Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for United Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.38% of United Therapeutics' floating shares are currently sold short.

Is United Therapeutics' short interest increasing or decreasing?

United Therapeutics saw a increase in short interest in August. As of August 31st, there was short interest totaling 3,240,000 shares, an increase of 68.8% from the previous total of 1,920,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is United Therapeutics' float size?

United Therapeutics currently has issued a total of 44,923,000 shares. Some of United Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. United Therapeutics currently has a public float of 43,890,000 shares.

How does United Therapeutics' short interest compare to its competitors?

7.38% of United Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sub-industry of "biotechnology" compare to United Therapeutics: Amgen Inc. (1.98%), Gilead Sciences, Inc. (0.00%), Regeneron Pharmaceuticals, Inc. (1.33%), Vertex Pharmaceuticals Incorporated (1.87%), Biogen Inc. (1.60%), Seagen Inc. (1.45%), Alnylam Pharmaceuticals, Inc. (0.00%), Exact Sciences Co. (0.00%), Novavax, Inc. (8.25%), and Repligen Co. (3.08%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Square, Inc. ($9.81 billion), S&P Global Inc. ($7.52 billion), Advanced Micro Devices, Inc. ($7.18 billion), Charter Communications, Inc. ($6.21 billion), Wayfair Inc. ($4.60 billion), Zoom Video Communications, Inc. ($3.23 billion), Uber Technologies, Inc. ($3.11 billion), Palo Alto Networks, Inc. ($2.74 billion), Teladoc Health, Inc. ($2.52 billion), and Etsy, Inc. ($2.16 billion). View all of the most shorted stocks.

What does it mean to sell short United Therapeutics stock?

Short selling UTHR is an investing strategy that aims to generate trading profit from United Therapeutics as its price is falling. United Therapeutics' stock is trading down $5.06 today. To short United Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that United Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against United Therapeutics?

A short squeeze for United Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of UTHR, which in turn drives the price of the stock up even further.

How often is United Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including UTHR, twice per month. The most recent reporting period available is August, 31 2021.



This page was last updated on 9/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.